The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Disclosure of Conflicts of Interest – Prof. Axel Glasmacher

This is a disclosure report regarding direct/indirect conflicts of interest of a financial, functional or any other nature related to commercial and non-commercial organizations.

Commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature (for the period of January-March 2023)

  • Member of Board of Directors (Current):
    • 4D Pharma (chairperson)
    • Active Biotech AB
    • Ryvu Therapeutics S.A.
  • Consultancy/other honoraria (2021-2023):
    • Bristol-Myers Squibb
    • Active Biotech AB
    • Nanexa AB
    • Cellex GmbH
    • Ryvu Therapeutics S.A.
    • Oncopeptides AB

Non-commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature

  • None

 

Last updated on 25 April 2023

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70